LEXINGTON, Mass., May 5, 2021 /PRNewswire/ -- Curis, Inc.
(NASDAQ: CRIS), a biotechnology company focused on the development
of innovative therapeutics for the treatment of cancer, today
announced that the Company will release its first quarter 2021
financial results on Wednesday, May 12,
2021, after the close of US markets. Management will host a
conference call on the same day at 4:30 pm
ET.
To access the live conference call, please dial (888) 346-6389
from the United States or (412) 317-5252 from other
locations, shortly before 4:30 pm ET. The conference call can
also be accessed on the Curis website at www.curis.com in
the 'Investors' section. A replay of the financial results
conference call will be available on the Curis website shortly
after completion of the call.
About Curis, Inc.
Curis is a biotechnology company focused on the development of
innovative therapeutics for the treatment of cancer. In 2015, Curis
entered into a collaboration with Aurigene in the areas of
immuno-oncology and precision oncology. As part of this
collaboration, Curis has exclusive licenses to oral small molecule
antagonists of immune checkpoints including the VISTA/PDL1
antagonist CA-170, and the TIM3/PDL1 antagonist CA-327, as well as
the IRAK4 kinase inhibitor, CA-4948. CA-4948 is currently
undergoing testing in a Phase 1 trial in patients with non-Hodgkin
lymphoma both as a monotherapy and in combination with BTK
inhibitor, ibrutinib. Curis is also evaluating CA-4948 in a Phase 1
trial in patients with acute myeloid leukemia and myelodysplastic
syndromes. In addition, Curis is engaged in a collaboration with
ImmuNext for development of CI-8993, a monoclonal anti-VISTA
antibody, which is currently undergoing testing in a Phase
1a/1b trial in patients with solid
tumors. Curis is also party to a collaboration with Genentech, a
member of the Roche Group, under which Genentech and Roche are
commercializing Erivedge® for the treatment of advanced basal cell
carcinoma. For more information, visit Curis' website at
www.curis.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/curis-to-release-first-quarter-2021-financial-results-and-hold-conference-call-on-may-12-2021-301283970.html
SOURCE Curis, Inc.